Department of Laboratory Medicine, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.
KingMed School of Laboratory Medicine, Guangzhou Medical University, Guangzhou, Guangdong, China.
Ann Clin Microbiol Antimicrob. 2023 Apr 21;22(1):28. doi: 10.1186/s12941-023-00580-4.
Mycoplasma hominis is one of the main opportunistic pathogenic mycoplasmas in humans which has a major impact on patients with bloodstream infections. Because it is difficult to detect or isolate, rapid and accurate diagnosis using improved methods is essential and still challenging for patients with bloodstream infection.
In this case, we reported the application of next -generation sequencing for the diagnosis of bloodstream infection caused by Mycoplasma hominis in a patient with Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis. After 9 days of combined treatment with levofloxacin, polymyxin B and meropenem, the patient's condition was gradually controlled and he was discharged without further complications. During the three-month outpatient follow-up, no recurrence of symptoms or clinical signs was reported.
This successful application of next generation sequencing assisted the rapid diagnosis of Mycoplasma hominis bloodstream infection, provided a new perspective in the clinical approach and highlighted the potential of this technique in rapid etiological diagnosis.
人型支原体是人类主要的机会致病性支原体之一,对血流感染患者有重大影响。由于难以检测或分离,因此使用改良方法进行快速准确的诊断对于血流感染患者至关重要,但仍然具有挑战性。
在本例中,我们报告了下一代测序在诊断抗中性粒细胞胞质抗体(ANCA)相关性血管炎患者由人型支原体引起的血流感染中的应用。在联合使用左氧氟沙星、多粘菌素 B 和美罗培南治疗 9 天后,患者的病情逐渐得到控制,无进一步并发症出院。在三个月的门诊随访中,未报告症状或临床体征复发。
下一代测序的成功应用辅助了人型支原体血流感染的快速诊断,为临床方法提供了新视角,并突出了该技术在快速病因诊断中的潜力。